DNM1L and cardiac hypertrophy: This idea is supported by Song et al. (2017), which has demonstrated that MFN1/MFN2/DRP1 triple knockout mice exhibit a unique form of cardiac hypertrophy and longer survival time when compared to MFN1/MFN2 or DRP1 cardiac knockout mice [192].